ADC-VI
ADC-VI (Compound 6) is a conjugate of a toxic molecule and a linker, in which the cytotoxin carried by CPD6 is Deruxtecan. Tricyclene is used to form an antibody-drug conjugate (ADC) by a chemical conjugation reaction through linking with an anti-FGFR2b antibody[1].
Product Specifications
CAS Number
3031725-06-8
UNSPSC
12352211
Target
Drug-Linker Conjugates for ADC
Related Pathways
Antibody-drug Conjugate/ADC Related
Field of Research
Cancer
Smiles
COCCOCCOCCOCCOC(C=C1COC(N[C@@H]2C3=C4C(C(N5C4)=CC([C@](O)(C(OC6)=O)CC)=C6C5=O)=NC7=CC(F)=C(C)C(CC2)=C73)=O)=C(C=C1)NC([C@H](C)NC([C@H](C(C)C)NC(CO[C@@H]8O[C@@H]([C@H]([C@@H]([C@H]8O)O)O)C(NCCN9C(C=CC9=O)=O)=O)=O)=O)=O
Molecular Formula
C63H77FN8O22
Molecular Weight
1317.32
References & Citations
[1]Panjiajia, et al. Resistance FGFR2b antibodies and antibody-drug conjugates. CN120424212 A.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
K1392303 1.0 µg DNA
NAT5 sgRNA CRISPR Lentivector (Human) (Target 2)
Sign In for Pricing
View Details